Association between maternal SARS-CoV-2 infection & clinical outcomes in infants: A multicentric retrospective cohort study in India
View abstract on PubMed
Summary
This summary is machine-generated.Maternal COVID-19 infection increases stillbirth risk and newborn intensive care unit admissions. Infant development milestones were unaffected in low- and middle-income countries.
Area Of Science
- Perinatal health
- Infectious disease epidemiology
- Child development
Background
- Limited data exists on COVID-19's impact on perinatal outcomes and infant development in low- and middle-income countries.
- Understanding these effects is crucial for maternal and child health strategies.
Purpose Of The Study
- To investigate the impact of maternal COVID-19 infection during pregnancy on neonatal outcomes.
- To assess the effect on infant development up to one year of age.
Main Methods
- Retrospective cohort study comparing pregnant women with and without COVID-19 exposure.
- Data collected via hospital records and maternal interviews.
- Propensity score matching used to minimize selection bias.
Main Results
- Maternal SARS-CoV-2 infection was linked to increased stillbirth risk (aOR 2.63) and higher admission rates to the special newborn care unit (SNCU) (aOR 2.57).
- Infants born to mothers with COVID-19 had a significantly higher risk of illness (RR 4.23).
- Developmental milestone attainment by age one was similar between exposed and unexposed infant cohorts.
Conclusions
- COVID-19 in pregnancy elevates the risk of stillbirth and necessitates increased SNCU admissions for newborns.
- No significant differences were observed in the age of developmental milestone achievement between infants of mothers with and without COVID-19.
Related Concept Videos
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

